Fertility Preservation in Young Women with Breast Cancer: Impact on Treatment and Outcomes
- 7 June 2022
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (9) , 5786-5796
Abstract
The impact of chemotherapy timing on the fertility preservation (FP) decision is poorly understood. Here we evaluate factors associated with FP completionKeywords
Funding Information
- NIH/NCI Cancer Center Support Grant (P30CA008748)
This publication has 30 references indexed in Scilit:
- Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast CancerJournal of Clinical Oncology, 2014
- Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2013
- Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancerFertility and Sterility, 2012
- Quality of Life, Fertility Concerns, and Behavioral Health Outcomes in Younger Breast Cancer Survivors: A Systematic ReviewJNCI: Journal of the National Cancer Institute, 2012
- Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent mannerFertility and Sterility, 2010
- Safety of Fertility Preservation by Ovarian Stimulation With Letrozole and Gonadotropins in Patients With Breast Cancer: A Prospective Controlled StudyJournal of Clinical Oncology, 2008
- Letrozole Reduces Estrogen and Gonadotropin Exposure in Women with Breast Cancer Undergoing Ovarian Stimulation before ChemotherapyThe Journal of Clinical Endocrinology & Metabolism, 2006
- Influence of Timing of Initiation of Adjuvant Chemotherapy Over Survival in Breast Cancer: A Negative Outcome Study by the Spanish Breast Cancer Research Group (GEICAM)Breast Cancer Research and Treatment, 2006
- Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27Journal of Clinical Oncology, 2006
- Fertility Preservation in Breast Cancer Patients: A Prospective Controlled Comparison of Ovarian Stimulation With Tamoxifen and Letrozole for Embryo CryopreservationJournal of Clinical Oncology, 2005